The beneficial effect of activated AMPK signaling for anti-NAFLD/NASH can be achieved by regulating the metabolic homeostasis of fatty acids, alleviating oxidative stress and inflammatory response, ameliorating fibrosis, and improving liver injury. Here, PRKAA2 is linked to metabolic dysfunction-associated steatotic liver disease.